Rebound Insomnia
- 20 April 1979
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 241 (16) , 1692-1695
- https://doi.org/10.1001/jama.1979.03290420018017
Abstract
Five benzodiazepine drugs (diazepam, flunitrazepam, flurazepam hydrochloride, nitrazepam, and triazolam) were evaluated separately in 15 sleep laboratory studies. Rebound insomnia, a worsening of sleep compared with baseline, occurred following withdrawal of triazolam, nitrazepam, and flunitrazepam after they had been given in only single, nightly doses for short periods. The rebound insomnia was attributed to the short and intermediate half-lives of these drugs. Diazepam and flurazepam, which have longer half-lives, did not cause rebound insomnia on withdrawal. Rebound insomnia may play a role in the development of hypnotic drug dependence with shorter-acting benzodiazepine drugs. (JAMA241:1692-1695, 1979)Keywords
This publication has 6 references indexed in Scilit:
- Rebound Insomnia: A New Clinical SyndromeScience, 1978
- Benzodiazepine Receptor: Demonstration in the Central Nervous SystemScience, 1977
- Clinical implications of benzodiazepine pharmacokineticsAmerican Journal of Psychiatry, 1977
- Clinical Pharmacokinetics of HypnoticsClinical Pharmacokinetics, 1977
- Anxiety and sleep after fosazepam.British Journal of Clinical Pharmacology, 1976
- Shortcomings in the Evaluation and Promotion of Hypnotic DrugsNew England Journal of Medicine, 1975